Valuation: Yuhan Corporation

Market Cap 5,765B 4.29B 3.85B 3.56B 3.22B 6.02B 408B 6.09B 42.54B 16.94B 214B 16.09B 15.75B 679B P/E 2026 *
39.6x
P/E 2027 * 28.4x
Enterprise Value 5.74B 4.27M 3.83M 3.54M 3.21M 6M 407M 6.07M 42.38M 16.88M 213M 16.04M 15.7M 676M EV / Sales 2026 *
2.45x
EV / Sales 2027 * 2.23x
Free-Float
59.15%
Yield 2026 *
0.78%
Yield 2027 * 0.75%
1 day-3.38%
1 week-10.32%
Current month+6.18%
1 month+4.32%
3 months+7.36%
6 months-17.85%
Current year-31.23%
1 week 76,800
Extreme 76800
86,500
1 month 69,000
Extreme 69000
89,800
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 53,809.52
Extreme 53809.523809
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 18/03/2021
Director of Finance/CFO 58 -
President 67 14/03/2024
Director TitleAgeSince
Chairman 74 18/03/2021
Director/Board Member 71 19/03/2015
Director/Board Member 62 29/02/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/06/25 Buy

Chairperson

200 0.0002%
25/06/25 Buy

Chief Executive Officer

720 0.0009%
24/06/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-3.38%-10.32%-35.31%+42.90% 4.5B
+0.47%+1.33%+57.02%+127.62% 1,143B
+0.84%+5.02%+44.82%+84.12% 647B
+0.37%+0.77%+26.13%+102.27% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-0.84%-6.13%+61.66%+37.02% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.38%+2.57%+53.93%+70.83% 242B
+0.25%+3.75%+35.17%+104.88% 197B
Average -0.22%-0.04%+32.97%+71.25% 403.2B
Weighted average by Cap. +0.25%+0.70%+44.35%+86.84%

Financials

2026 *2027 *
Net sales 2,348B 1.75B 1.57B 1.45B 1.31B 2.45B 166B 2.48B 17.32B 6.9B 87.05B 6.55B 6.42B 276B 2,549B 1.9B 1.7B 1.57B 1.42B 2.66B 181B 2.69B 18.81B 7.49B 94.51B 7.12B 6.97B 300B
Net income 150B 112M 100M 92.52M 83.79M 157M 10.62B 158M 1.11B 441M 5.56B 419M 410M 17.65B 201B 150M 134M 124M 112M 210M 14.25B 212M 1.48B 591M 7.45B 561M 549M 23.67B
Net Debt -20.82B -15.49M -13.9M -12.85M -11.64M -21.74M -1.48B -22.01M -154M -61.2M -772M -58.13M -56.91M -2.45B -83.34B -62M -55.63M -51.43M -46.58M -87.02M -5.9B -88.07M -615M -245M -3.09B -233M -228M -9.81B
Projected Income Statement - Annual - Yuhan Corporation
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,082
Date Price Change Volume
27/10/26 ₩77,300.00 -3.38% 331,407
27/10/26 ₩80,000.00 -2.08% 196,144
26/10/26 ₩81,700.00 -3.54% 165,207
23/10/26 ₩84,700.00 +0.83% 386,541
22/10/26 ₩84,000.00 -3.00% 340,784
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Yuhan Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
77,300.00KRW
Average target price
112,058.82KRW
Spread / Average Target
+44.97%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Yuhan Corporation
  1. Stock Market
  2. Stocks
  3. A000100 Stock